| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T419 |
0-188 |
Sentence |
denotes |
Currently, there are multiple in vitro experiments and preclinical studies being performed around the world to test novel COVID-19 therapies, which are quickly moving into clinical trials. |
| T420 |
189-338 |
Sentence |
denotes |
Importantly, the early efficacy results have been limited to small-scale clinical studies in which the safety profiles have not been well-identified. |
| T421 |
339-463 |
Sentence |
denotes |
The safety profiles will be critical for COVID-19 patients with underlying comorbidities such as cardiovascular dysfunction. |
| T422 |
464-625 |
Sentence |
denotes |
Therefore, as there is a need for rapid clinical translation and a wide use of novel therapies for COVID-19, continued attention to safety profiles is important. |
| T423 |
626-777 |
Sentence |
denotes |
The rapid spread of COVID-19 globally continues to impact susceptible populations, like elderly patients and individuals with underlying comorbidities. |
| T424 |
778-1027 |
Sentence |
denotes |
While underlying cardiovascular issues are impacted by COVID-19 infection, many existing and novel therapeutic strategies have direct adverse cardiovascular effects, highlighting the importance for consideration in new drug research and development. |
